Eli Lilly & Co.

LLY NYS
Pharmaceuticals
Indianapolis, IN
2016 Revenue (US$ Millions)$21,222
Revenue Growth (%)6.33%
2015 Revenue (US$ Millions)$19,959
Net Income (US$ Millions)$2,738
Common Shares Outstanding (Millions)1,100.88
Earnings Per Share (US$)$2.58
Price to Earnings Ratio32.53
Total Equity (US$ Millions)$14,008
Return on Equity (%)18.79%
Long Term Debt (US$ Millions)$8,368
Debt to Equity Ratio (%)0.60%
Market Capitalization (US$ Millions)$80,969
Total Assets (US$ Millions)$38,806
Current Assets (US$ Millions)$15,101
Inventories (US$ Millions)$3,562
Current Liabilities (US$ Millions)$10,987
Cost Of Goods Sold (US$ Millions)$5,655
Asset Turnover0.57
Inventory Turnover1.61